Given the role of AMPK in pro-survival signalling38 and the compensatory upregulation of ACSS2 upon ACLY inhibition8,9,12, these findings highlight key mechanistic differences between EVT0185 and bempedoic acid and supported continued development of EVT0185 for HCC. Here, ACSS2 is linked to hepatocellular carcinoma.